Back to funds

BOONE CAPITAL MANAGEMENT LLC

Updated 6 days ago

Managed by Boone Capital Management Llc • Latest filing Q3 2026

Portfolio value
$376.7M
Q3 2026
Filings
4
Quarterly 13F history
Top-10 concentration
100.0%
Weight of largest holdings
Annualized return
—
Implied from 13F holdings

Portfolio value history

13F-disclosed portfolio value over 4 quarters

Show data table
PeriodPortfolio value
Q4 2025$318.6M
Q1 2026$326.4M
Q2 2026$427.5M
Q3 2026$376.7M

Top holdings

16 positions as of Q3 2026

View filing
B

BIOMARIN PHARMACEUTICAL INC

Value
$40.3M
Shares
672.0K
% Port
10.70%
T

TELEFLEX INCORPORATED

Value
$36.1M
Shares
288.9K
% Port
9.59%
M

MIRUM PHARMACEUTICALS INC

Value
$35.5M
Shares
415.6K
% Port
9.43%
U

UNITEDHEALTH GROUP INC

Value
$32.6M
Shares
88.7K
% Port
8.64%
C

THE CIGNA GROUP

Value
$30.5M
Shares
112.3K
% Port
8.10%
G

GUARDIAN PHARMACY SVCS INC

Value
$29.6M
Shares
725.1K
% Port
7.85%
A

AVANTOR INC

Value
$27.7M
Shares
1.84M
% Port
7.35%
L

LABCORP HOLDINGS INC

Value
$27M
Shares
87.6K
% Port
7.16%
E

ENCOMPASS HEALTH CORP

Value
$25M
Shares
205.8K
% Port
6.64%
V

VESTIS CORPORATION

Value
$21.2M
Shares
1.58M
% Port
5.62%
P

PENNANT GROUP INC

Value
$20.5M
Shares
525.9K
% Port
5.44%
B

BRIDGEBIO PHARMA INC

Value
$18.3M
Shares
277.4K
% Port
4.85%
W

WAYSTAR HLDG CORP

Value
$12.9M
Shares
508.6K
% Port
3.42%
C

CULLINAN THERAPEUTICS INC

Value
$10.6M
Shares
690.8K
% Port
2.81%
M

MAZE THERAPEUTICS INC

Value
$4.9M
Shares
179.5K
% Port
1.30%
A

ADLAI NORTYE GROUP LTD

Value
$4.1M
Shares
258.4K
% Port
1.10%

Explore